Skip to content
ClinCalc Pro
Menu
Topical scalp preparation

Coal tar with coconut oil and salicylic acid

Brand names: Cocois, Capasal

A topical (typically scalp) preparation combining coal tar with coconut oil and salicylic acid, used for scaling scalp conditions such as psoriasis, seborrhoeic dermatitis, dandruff and cradle cap.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Coal tar provides anti-inflammatory, antiscaling and antipruritic action, salicylic acid is a keratolytic that softens and lifts adherent scale, and coconut oil acts as an emollient base that loosens crusts and aids removal of scale.

Prescribing in practice

  • Coal tar increases photosensitivity, so the scalp and any treated skin should be protected from strong sunlight, with extra care if phototherapy is used.
  • Keep the preparation away from the eyes and broken or inflamed skin, as both tar and salicylic acid can cause irritation.
  • Salicylic acid is absorbed percutaneously, so avoid widespread application especially in young children to limit the risk of salicylate toxicity.

Monitoring

No laboratory monitoring is generally required; review the scalp for irritation and response to treatment.

Counselling the patient

  • Massage into the scalp as directed and rinse out; take care to avoid the eyes.
  • Expect a tar smell and possible staining of light or bleached hair.
  • Stop and seek advice if the scalp becomes sore or irritated.

Evidence & guidelines

Combined coal tar and salicylic acid scalp preparations are well-established for scaling scalp disorders and feature in stepped topical care for scalp psoriasis.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.